China Industry News (cinn.cn) reported on Eynos at the Cell Biology Industry Conference and its biopharma expo, covering the product-line layout, the two conjugation routes and the QC practices presented at the technical forum.
This page summarises a media report about Eynos. Quoted wording — including terms such as "breakthrough", "on par with", "first" or "unique" — is the original reporter's language and is not a performance claim by the company. Product performance is defined by the manual and the measured data. All products are for research use only (RUO) and are not intended for diagnostic or therapeutic use.
The report frames the piece around the Cell Biology Industry Conference and its biopharma expo, at which Eynos showed its cell-isolation reagent range and presented its product layout and quality-control practice at a parallel technical forum. Its argument is that a complete product line — negative and positive selection, for human and mouse samples — is what lets a lab run isolation and the downstream work inside one technical system.
The layout is grouped by species and by separation format: column-free negative selection for human (SN3) and mouse (SN4), column-based negative selection for human (CBS3) and mouse (CBS4), and column-based positive selection for human (PH) and mouse (PM) — plus a depletion series (EasyDep) and a streptavidin nanobead (S2001) on which users can build custom column-free positive selection.
On technology, the report contrasts two routes rather than ranking them: direct antibody conjugation (used in the PH and PM series) needs fewer steps and usually finishes a single sample inside twenty minutes, while the biotinylated-antibody plus streptavidin-bead route makes it easier to swap the detection antibody for multiplex enrichment. It also flags a boundary worth repeating: ordinary positive-selection beads do not carry activating antibodies, whereas T-cell activation beads do by design, so the two should not be mixed.
The QC section lists three practices: standardised manuals that record sample type, starting cell number, bead-to-cell ratio, incubation time and temperature, magnet residence time and the recommended flow-cytometry clone, together with each lot's validated starting frequency and final purity; batch COAs searchable online by catalogue number; and catalogue numbers cross-linked to published literature. The report also describes a dose-titration test on the human CD4 isolation beads — recommended dose versus half dose, on PBMC: at the lower dose, clearance of non-target cells fell and background rose, while purity inside the CD3⁺ gate changed comparatively little.
The full report is published in Chinese: 中文原文. The original article is available at cinn.cn. This page is an English summary prepared by Eynos.
Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.